ANI Pharmaceuticals ANIP Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's total current assets?
- ANI Pharmaceuticals (ANIP) reported total current assets of $747.08M in Q1 2026.
- How has ANI Pharmaceuticals's total current assets changed year-over-year?
- ANI Pharmaceuticals's total current assets increased by 39.3% year-over-year, from $536.29M to $747.08M.
- What is the long-term trend for ANI Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's total current assets has grown at a 34.6% compound annual growth rate (CAGR), from $170.32M to $753.12M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.